These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. Gilhus NE; Matre R; Aarli JA Int J Immunopharmacol; 1982; 4(1):43-8. PubMed ID: 6979523 [TBL] [Abstract][Full Text] [Related]
29. Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients. Zare M; Ghazvini MR; Yazdi HR; Nezhad VS; Chitsaz A Eur Neurol; 2008; 59(6):299-301. PubMed ID: 18408370 [TBL] [Abstract][Full Text] [Related]
30. [Effect of phenytoin on immunoglobulins A, G and M]. Jadot G; Valli M; Bussiere H; Bruguerolle B; Bouyard P Nouv Presse Med; 1982 Dec; 11(51):3796-7. PubMed ID: 7155886 [No Abstract] [Full Text] [Related]
31. Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Bardana EJ; Gabourel JD; Davies GH; Craig S Am J Med; 1983 Feb; 74(2):289-96. PubMed ID: 6600585 [TBL] [Abstract][Full Text] [Related]
32. Phenytoin influence on human lymphocyte mitogen response: a prospective study of epileptic and nonepileptic patients. Gabourel JD; Davies GH; Bardana EJ; Ratzlaff NA Epilepsia; 1982 Aug; 23(4):367-76. PubMed ID: 7094904 [TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin abnormalities in relatives of IgA deficient epileptics. Fontana A; Grob PJ; Sauter R J Neurol; 1978 Feb; 217(3):207-12. PubMed ID: 75956 [TBL] [Abstract][Full Text] [Related]
34. Suppression of IgA production by lymphocytes induced by diphenylhydantoin. Kondo N; Takao A; Tomatsu S; Shimozawa N; Suzuki Y; Ogawa T; Iwata H; Orii T J Investig Allergol Clin Immunol; 1994; 4(5):255-7. PubMed ID: 7874323 [TBL] [Abstract][Full Text] [Related]
35. Reduced CSF IgG in patients treated with phenytoin (diphenylhydantoin). Fossan GO Eur Neurol; 1976; 14(6):426-32. PubMed ID: 991879 [TBL] [Abstract][Full Text] [Related]
36. [Transient lowering of the IgA level during Diphedan therapy]. Balogh E; Máttyus A; Németh C; Szabadosné NM Orv Hetil; 1979 Sep; 120(36):2179-82. PubMed ID: 514604 [No Abstract] [Full Text] [Related]
37. Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy. Fontana A; Joller H; Skvaril F; Grob P J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):593-7. PubMed ID: 99491 [TBL] [Abstract][Full Text] [Related]
38. Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients. Gilhus NE; Aarli JA Acta Neurol Scand; 1981 Jan; 63(1):34-43. PubMed ID: 7468159 [TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. Patel K; Akhter J; Kobrynski L; Benjamin Gathmann MA; Davis O; Sullivan KE; J Pediatr; 2012 Nov; 161(5):950-3. PubMed ID: 22809661 [TBL] [Abstract][Full Text] [Related]
40. Effect of diphenylhydantoin in serum and secretory IgA concentrations. Martínez-Cairo S; Guiscafre H; Alvarez MT; Muñóz-Hernández O Arch Invest Med (Mex); 1980; 11(1):1-8. PubMed ID: 6772121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]